Efficacy, safety, and immunogenicity of the human papillomavirus 16/18 AS04-adjuvanted vaccine in women older than 25 years: 7-year follow-up of the phase 3, double-blind, randomised controlled VIVIANE study
Wheeler, Cosette M, Prof, Skinner, S Rachel, Prof, Del Rosario-Raymundo, M Rowena, MD, Garland, Suzanne M, Prof, Chatterjee, Archana, Prof, Lazcano-Ponce, Eduardo, Prof, Salmerón, Jorge, Prof, McNeil, Shelly, Prof, Stapleton, Jack T, Prof, Bouchard, Céline, FRCSC, Martens, Mark G, MD, Money, Deborah M, Prof, Quek, Swee Chong, MBBCh, Romanowski, Barbara, Prof, Vallejos, Carlos S, MD, ter Harmsel, Bram, PhD, Prilepskaya, Vera, PhD, Fong, Kah Leng, MRCOG, Kitchener, Henry, Prof, Minkina, Galina, Prof, Lim, Yong Kuei Timothy, MBBS, Stoney, Tanya, MBBS, Chakhtoura, Nahida, MD, Cruickshank, Margaret E, Prof, Savicheva, Alevtina, PhD, da Silva, Daniel Pereira, MD, Ferguson, Murdo, MD, Molijn, Anco C, MSc, Quint, Wim G V, PhD, Hardt, Karin, PhD, Descamps, Dominique, MD, Suryakiran, Pemmaraju V, MSc, Karkada, Naveen, MSc, Geeraerts, Brecht, PhD, Dubin, Gary, MD, Struyf, Frank, MD
Published in The Lancet infectious diseases (01.10.2016)
Published in The Lancet infectious diseases (01.10.2016)
Get full text
Journal Article
REMOVED: Cervical Cancer Prevention: Understanding Current Clinical Data for Prophylactic Vaccines
Martens, Mark G., MD, Shaw, Howard A., MD
Published in The American journal of medicine (01.08.2009)
Published in The American journal of medicine (01.08.2009)
Get full text
Journal Article